A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-9545, in postmenopausal women with estrogen receptor-positive (ER(+)) HER2-negative (HER2(-)) metastatic breast cancer Meeting Abstract
| Authors: | Jhaveri, K.; Winer, E. P.; Lim, E.; Fidalgo, J. A. P.; Bellet, M.; Mayer, I. A.; Boni, V.; Patel, J. M.; Bardia, A.; Garcia, J. M.; Kabos, P.; Gates, M.; Chen, Y. C.; Fredrickson, J.; Wang, X.; Friedman, L. S.; Spoerke, J.; Gendreau, S.; Metcalfe, C.; Liu, L.; Chang, C. W.; Monemi, S.; Gonzalez, M.; McCurry, U.; Milan, S.; Humke, E. W.; Loi, S. |
| Abstract Title: | A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-9545, in postmenopausal women with estrogen receptor-positive (ER(+)) HER2-negative (HER2(-)) metastatic breast cancer |
| Meeting Title: | 42nd Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000527012503329 |
| DOI: | 10.1158/1538-7445.Sabcs19-pd7-05 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: PD7-05 -- Source: Wos |
